We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STR
6351
DELISTED
Sitio Royalties
STR
$1K ﹤0.01%
25
+24
+2,400% +$926
TAOP icon
6352
Taoping
TAOP
$6.14M
0
TARA icon
6353
Protara Therapeutics
TARA
$227M
$1K ﹤0.01%
+10
New +$910
VNCE icon
6354
Vince Holding Corp
VNCE
$80.7M
$1K ﹤0.01%
166
-4
-2% -$31
LFWD icon
6355
ReWalk Robotics
LFWD
$19.7M
0
JXG
6356
JX Luxventure
JXG
$84.3M
0
BYU
6357
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
0
DXYN
6358
DELISTED
Dixie Group Inc
DXYN
$1K ﹤0.01%
300
-6,395
-96% -$20.8K
NBSE
6359
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1K ﹤0.01%
9
-1
-10% -$149
EMAN
6360
DELISTED
eMagin Corporation
EMAN
$1K ﹤0.01%
1,090
-1,660
-60% -$2.56K
PLXP
6361
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$1K ﹤0.01%
382
-70
-15% -$443
GRU
6362
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Grains Total Return
GRU
$1K ﹤0.01%
300
MBII
6363
DELISTED
Marrone Bio Innovations, Inc.
MBII
$1K ﹤0.01%
480
TCCO
6364
DELISTED
Technical Communications Corporation
TCCO
$1K ﹤0.01%
275
-100
-27% -$808
PBBI
6365
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$1K ﹤0.01%
159
-15
-9% -$157
BLPH
6366
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1K ﹤0.01%
33
ESTRW
6367
DELISTED
Estre Ambiental, Inc
ESTRW
$1K ﹤0.01%
2,100
IDXG
6368
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$1K ﹤0.01%
62
+22
+55% +$226
AMRWW
6369
DELISTED
Alta Mesa Resources Inc Warrant
AMRWW
$1K ﹤0.01%
+406
New +$704
BORN
6370
DELISTED
China New Borun Corporation
BORN
$1K ﹤0.01%
500
VISL
6371
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$1K ﹤0.01%
+1
New +$1.73K
CYHHZ
6372
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
57,396
-600
-1% -$4
DGAZ
6373
DELISTED
VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return
DGAZ
$1K ﹤0.01%
1
SHLDW
6374
DELISTED
Sears Holdings Corporation - Warrant
SHLDW
$1K ﹤0.01%
3,890
+35
+0.9% +$12
EGLT
6375
DELISTED
Egalet Corporation
EGLT
$1K ﹤0.01%
1,210
-2,200
-65% -$1.9K

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.